Pierrefonds, Canada

Michel Meunier

USPTO Granted Patents = 7 

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1999-2021

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Michel Meunier: Innovator in Biomolecular Delivery Systems

Introduction

Michel Meunier is a prominent inventor based in Pierrefonds, Canada. He has made significant contributions to the field of biomolecular delivery systems, holding a total of seven patents. His innovative work focuses on methods that enhance the delivery of therapeutic agents into the eye, showcasing his expertise in both medical technology and materials science.

Latest Patents

Among his latest patents, Meunier has developed a method and system for delivering exogenous biomolecules into the eye. This method involves injecting a mixture of exogenous biomolecules and plasmonic structures into a specific region of the eye. The plasmonic structures, which resonate at a particular wavelength, are then irradiated with a laser beam. This process creates pores in the membranes of target cells, allowing the biomolecules to enter effectively. Another notable patent involves the preparation of alloy nanoparticles, which are synthesized through a combination of co-reduction of metal salts and multi-step seeded growth synthesis. These nanoparticles have a controlled size and are made from at least two metals, demonstrating Meunier's innovative approach to nanotechnology.

Career Highlights

Throughout his career, Michel Meunier has worked with various companies, including Cadeka Microcircuits and Technologies Ltrim Inc. His experience in these organizations has allowed him to apply his research in practical settings, further advancing the field of biomolecular delivery.

Collaborations

Meunier has collaborated with notable professionals in his field, including Yves Gagnon and Yvon Savaria. These partnerships have contributed to the development of his innovative technologies and have fostered a collaborative environment for research and development.

Conclusion

Michel Meunier's work in biomolecular delivery systems exemplifies the intersection of innovation and practical application in medical technology. His patents reflect a commitment to advancing therapeutic methods, making significant strides in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…